[HTML][HTML] Fentanyl in cancer pain management: avoiding hasty judgments and discerning its potential benefits
A Cuomo - Drugs in Context, 2023 - ncbi.nlm.nih.gov
Cancer pain is an important challenge in treatment and requires a rapid onset of action for
its control. In particular, breakthrough cancer pain (BTcP) should be adequately controlled …
its control. In particular, breakthrough cancer pain (BTcP) should be adequately controlled …
A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with …
S Novotna, K Valentova, J Fricova, E Richterova… - Clinical …, 2014 - Elsevier
Background Oromucosal fentanyl is currently used for the treatment of breakthrough pain
(BTP) in opioid-treated cancer patients. Ethypharm developed a sublingual formulation of …
(BTP) in opioid-treated cancer patients. Ethypharm developed a sublingual formulation of …
[HTML][HTML] Fentanyl for the treatment of tumor-related breakthrough pain
H Bornemann-Cimenti, M Wejbora… - Deutsches Ärzteblatt …, 2013 - ncbi.nlm.nih.gov
Background Breakthrough cancer pain (BTCP) is common among cancer patients and
markedly lowers their quality of life. The treatment for BTCP episodes that is recommended …
markedly lowers their quality of life. The treatment for BTCP episodes that is recommended …
Fentanyl for breakthrough cancer pain: where are we?
F Meriggi, A Zaniboni - Reviews on Recent Clinical Trials, 2013 - ingentaconnect.com
Despite relative stable and adequately controlled background pain, Breakthrough Cancer
Pain (BTcP) is a transient exarcebation of pain that occurs either spontaneously or in …
Pain (BTcP) is a transient exarcebation of pain that occurs either spontaneously or in …
Efficacy of sublingual fentanyl vs. oral morphine for cancer-related breakthrough pain
I Velázquez Rivera, JC Muñoz Garrido… - Advances in …, 2014 - Springer
Abstract Introduction Breakthrough cancer pain (BTcP) is recognized as a clinically
significant complication of chronic cancer pain with most BTcP episodes peaking in intensity …
significant complication of chronic cancer pain with most BTcP episodes peaking in intensity …
Treating breakthrough pain in oncology
S Mercadante - Expert review of anticancer therapy, 2018 - Taylor & Francis
ABSTRACT Introduction: Breakthrough cancer pain (BTcP) is an episode of severe intensity
in patients receiving an adequate treatment with opioids able to provide at least mild …
in patients receiving an adequate treatment with opioids able to provide at least mild …
The role of fentanyl in cancer-related pain
E Prommer - Journal of palliative medicine, 2009 - liebertpub.com
Fentanyl is a lipophilic, short-acting, synthetic opioid with a piperidine chemical structure.
Fentanyl is an effective analgesic for cancer pain, and newer formulations such as the …
Fentanyl is an effective analgesic for cancer pain, and newer formulations such as the …
[HTML][HTML] Fentanyl buccal tablet vs. oral morphine in doses proportional to the basal opioid regimen for the management of breakthrough cancer pain: a randomized …
S Mercadante, C Adile, A Cuomo, F Aielli… - Journal of pain and …, 2015 - Elsevier
Context Fentanyl products have shown superiority to oral opioids for the management of
breakthrough cancer pain (BTcP). However, these studies did not use appropriate patient …
breakthrough cancer pain (BTcP). However, these studies did not use appropriate patient …
[HTML][HTML] A new fast-acting sublingual fentanyl (Recivit®) for treating breakthrough cancer pain
A Davies - Eur Oncol Haematol, 2014 - touchoncology.com
Overview Cancer pain presents a significant clinical challenge. Even when background pain
is effectively controlled, patients often experience episodes of breakthrough cancer pain …
is effectively controlled, patients often experience episodes of breakthrough cancer pain …
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain
RL Rauck, M Tark, E Reyes, TG Hayes… - … medical research and …, 2009 - Taylor & Francis
Background and objectives: Breakthrough cancer pain (BTcP) represents an important
clinical challenge in the care of patients with cancer. This trial evaluated the efficacy and …
clinical challenge in the care of patients with cancer. This trial evaluated the efficacy and …